Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
VTRS:NASDAQ
Viatris Inc
15,04 US$
+0,67%
(+0,10) 1D
15,04 US$
0,00% (0,00)
After hours
Closed: 1 may, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTRS...
Açın
14,95 US$
High
15,08 US$
Low
14,78 US$
Mkt. cap
17,51 mlrd
Avg. vol.
9,54 mln
Volume
7,36 mln
Dividend
3,19%
Quarterly dividend
0,12 US$
Ex dividend date
9 mar 2026
52-wk high
16,47 US$
52-wk low
7,80 US$
EPS
-3,00 US$
Beta
0,83
Shares outstanding
1,16 mlrd
No. of employees
30K
News stories
From sources across the web
Profile
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue. Wikipedia
About Viatris Inc
CEOScott A. Smith
Employees30K
Founded16 noy 2020
HeadquartersCanonsburg, Pensilvaniya, Amerika Birləşmiş Ştatları
SectorPharmaceutical industry
Websiteviatris.com
Next call 5 gün ərzində
7 may, C.a., 08:30
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (0,50 est.)USD
Revenue / Estimate
-/ (3,36 mlrd est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
3,25 mlrd
3,58 mlrd
3,76 mlrd
3,70 mlrd
Cost of goods sold
2,02 mlrd
2,15 mlrd
2,26 mlrd
2,21 mlrd
Cost of revenue
2,02 mlrd
2,15 mlrd
2,26 mlrd
2,21 mlrd
Research and development expenses
220,50 mln
216,00 mln
244,80 mln
271,20 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
829,70 mln
857,30 mln
848,50 mln
933,40 mln
Operating expense
1,05 mlrd
1,07 mlrd
1,09 mlrd
1,20 mlrd
Total operating expenses
3,07 mlrd
3,23 mlrd
3,36 mlrd
3,42 mlrd
Operating income
184,60 mln
356,40 mln
404,60 mln
288,20 mln
Other non operating income
148,90 mln
-110,40 mln
-135,90 mln
44,90 mln
EBT including unusual items
-3,10 mlrd
-217,10 mln
-7,90 mln
-343,00 mln
EBT excluding unusual items
108,10 mln
254,70 mln
318,70 mln
188,00 mln
Income tax expense
-55,00 mln
-212,50 mln
120,30 mln
-2,90 mln
Effective tax rate
1,78%
97,88%
-1.522,78%
0,85%
Other operating expenses
-
-
-
-
Net income
-3,04 mlrd
-4,60 mln
-128,20 mln
-340,10 mln
Net profit margin
-93,48%
-0,13%
-3,41%
-9,18%
Earnings per share
0,50
0,62
0,67
0,57
Interest and investment income
-
-
-
-
Interest expense
-115,50 mln
-116,60 mln
-119,60 mln
-119,60 mln
Net interest expenses
-115,50 mln
-116,60 mln
-119,60 mln
-119,60 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
849,30 mln
1,03 mlrd
1,09 mlrd
981,10 mln
Gain or loss from assets sale
36,90 mln
43,80 mln
-1,60 mln
21,90 mln
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer